The Moment
“Michael”, the authorized Michael Jackson biopic, just moonwalked past the $700 million mark worldwide. Studio estimates peg the cumulative gross at roughly $703 million as of this weekend, with about $421 million from overseas markets and $282 million from domestic markets. In its fourth weekend, it also climbed back to the top spot internationally, adding an estimated $57 million.
And here’s the kicker: those totals do not yet include Japan, where the film opens June 12. So yes, the runway is still extending.
Directed by Antoine Fuqua and fronted by Jaafar Jackson (Michael’s nephew), the film opened on April 24 and has been playing like a greatest-hits tour that keeps selling out, even as critics remain skeptical.
The Take
I’ll be blunt: music biopics were supposed to be “over,” right? We had the wave (“Bohemian Rhapsody”, “Rocketman”, “Elvis”) and then the think pieces said the genre was running on fumes. And yet here comes “Michael”, pulling numbers that make studio accountants giddier than a surprise encore.
What’s hype-versus-reality? The hype is the box office drumbeat that treats every milestone like a coronation. The reality is simpler and more interesting. This movie leverages three potent forces: global nostalgia, the irresistible promise of seeing a legend “from the inside,” and a canny casting story. Jaafar Jackson doesn’t just look the part; he feels like living authorized access. Whether you loved or shrugged at the film, audiences are filing in for the performances, the myth, and the memory. It’s the entertainment version of a legacy tour critics may sniff at, but fans pack the arena anyway.
Does it overtake “Bohemian Rhapsody’s” towering $911 million tally to become the highest-grossing music biopic ever? That’s still a climb. But with Japan still off the board, the math isn’t fantasy. The more interesting read is what it says about us: audiences want familiar myths told big, with recognizable hits and clean narrative arcs. We say we crave “new,” but at the box office we’re often buying reverent remixes, especially when the icon remains one of pop culture’s north stars, with controversies and complexities acknowledged.
Receipts
Confirmed:
- Cumulative global gross is reported at approximately $703 million as of the latest weekend. International weekend #4 added an estimated $57 million. The domestic/overseas split sits at $282M/$421M. Japan opens June 12. These are studio and industry-tracking estimates for the current frame.
- Release date April 24; directed by Antoine Fuqua; cast includes Jaafar Jackson, Nia Long, Laura Harrier, Juliano Krue Valdi, Miles Teller, and Colman Domingo. These details come from official film materials.
- Critical and audience response has been notably divided, per widely used review aggregators.
Unverified/Reported:
- Whether “Michael” ultimately surpasses “Bohemian Rhapsody’s” ~$911 million lifetime gross remains uncertain; that is a performance projection, not a done deal.
Backstory (for Casual Readers)
Michael Jackson, arguably the most famous pop star of the modern era, left a seismic cultural footprint and a complicated legacy. The new biopic, made with the estate’s cooperation, follows his rise from Jackson 5 prodigy to a global phenomenon and leans into the performances and iconography that defined late-20th-century pop. Biopics about music legends have been strong box-office performers lately: “Bohemian Rhapsody” (2018) topped $900 million worldwide, while “Elvis” (2022) earned just under $300 million. “Michael” has already blown past “Elvis” and is now eyeing the top spot on the all-time music-biopic leaderboard.
What’s Next
Circle June 12: Japan’s launch could provide a meaningful boost if word-of-mouth holds. Watch for how well the film legs it through weekend five and beyond, especially as new releases crowd the calendar. International expansion patterns, premium-format retention (IMAX and PLF screens), and soundtrack/playlist bumps could all help keep momentum.
Beyond box office, keep an eye on awards-season chatter (performance categories in particular) and the home release window. If the film continues to dominate overseas while staying steady domestically, the “highest-grossing music biopic” crown could shift before the summer’s out, but only if those late-stage markets dance to the beat.
Does box office dominance change how you feel about a polarizing music biopic, or do you keep reviews and receipts in separate lanes?
Comments